TY - JOUR
T1 - Trading Vulnerabilities
T2 - Living with Parkinson's Disease before and after Deep Brain Stimulation
AU - Goering, Sara
AU - Wexler, Anna
AU - Klein, Eran
N1 - Funding Information:
Interviews for this study were supported by the National Institutes of Health (NIH) and National Institute of Neurological Disorders and Stroke (NINDS) via grant number U01NS103799. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We would also like to thank Rebekah Choi for research assistance, and the University of Washington Neuroethics Research Group for their feedback on the project.
Funding Information:
Interviews for this study were supported by the National Institutes of Health (NIH) and National Institute of Neurological Disorders and Stroke (NINDS) via grant number U01NS103799. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We would also like to thank Rebekah Choi for research assistance, and the University of Washington Neuroethics Research Group for their feedback on the project.
Publisher Copyright:
© 2021 The Author(s). Published by Cambridge University Press.
PY - 2021/10/1
Y1 - 2021/10/1
N2 - Implanted medical devices - for example, cardiac defibrillators, deep brain stimulators, and insulin pumps - offer users the possibility of regaining some control over an increasingly unruly body, the opportunity to become part cyborg in service of addressing pressing health needs. We recognize the value and effectiveness of such devices, but call attention to what may be less clear to potential users - that their vulnerabilities may not entirely disappear but instead shift. We explore the kinds of shifting vulnerabilities experienced by people with Parkinson's disease (PD) who receive therapeutic deep brain stimulators to help control their tremors and other symptoms of PD.
AB - Implanted medical devices - for example, cardiac defibrillators, deep brain stimulators, and insulin pumps - offer users the possibility of regaining some control over an increasingly unruly body, the opportunity to become part cyborg in service of addressing pressing health needs. We recognize the value and effectiveness of such devices, but call attention to what may be less clear to potential users - that their vulnerabilities may not entirely disappear but instead shift. We explore the kinds of shifting vulnerabilities experienced by people with Parkinson's disease (PD) who receive therapeutic deep brain stimulators to help control their tremors and other symptoms of PD.
KW - Parkinson's disease
KW - cyborg
KW - deep brain stimulation
KW - implanted medical devices
KW - vulnerability
UR - http://www.scopus.com/inward/record.url?scp=85118114107&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118114107&partnerID=8YFLogxK
U2 - 10.1017/S0963180121000098
DO - 10.1017/S0963180121000098
M3 - Article
C2 - 34702406
AN - SCOPUS:85118114107
SN - 0963-1801
VL - 30
SP - 623
EP - 630
JO - Cambridge Quarterly of Healthcare Ethics
JF - Cambridge Quarterly of Healthcare Ethics
IS - 4
ER -